Posted by Michael Wonder on 16 Aug 2022
Kidney patients cite insurance and payment issues as critical barriers to FDA approved care innovations
15 August 2022 - Patients and taxpayers forced to absorb preventable costs.
The American Association of Kidney Patients unveiled an aggressive consumer engagement and mobilisation campaign to help patients engage their commercial insurers and the Centers for Medicare and Medicaid Services' on coverage decisions that undermine patient access to new and safe care innovations approved by the US FDA.
